Neuroscience
A synthetic peptide fragment studied in preclinical mood and neuroplasticity research.
A synthetic peptide fragment studied in preclinical mood and neuroplasticity research.
Evidence map
Evidence levels describe study design. They do not by themselves establish safety or effectiveness.
Shortened Spadin Analogs Display Better TREK-1 Inhibition, In Vivo Stability and Antidepressant Activity.
Shortened Spadin Analogs Display Better TREK-1 Inhibition, In Vivo Stability and Antidepressant Activity.
Gonzalo Castro, PhD, PE, NAE, F.ASCE
Kord Wissmann, PhD, PE, D.GE, M.ASCE
Untitled Crossref work
Untitled Crossref work
Bleeding Risk Scores Identified Patients With DVT or PE at Low Risk of Bleeding
Classification Method of Warehouse Inventory Data Based on PE-AdaBoost Algorithm
Untitled Crossref work
Untitled Crossref work
Connected data hub
Reviewed records carry an admin-reviewed badge. Automated records link back to the provider for independent checking.
Djillani A, Pietri M, Moreno S, Heurteaux C, Mazella J, Borsotto M · Frontiers in pharmacology
Djillani A, Pietri M, Moreno S, Heurteaux C, Mazella J, Borsotto M
Junyang Liu · Hill Publishing Group Inc.
· Coordinacion de Publicaciones de la Escuela Superior de Economia
Kaitlin Hall, Wenyong Rong, Yewei Zheng, Tugce Baser · American Society of Civil Engineers (ASCE)
Amanda Parry, Corey Snider · American Society of Civil Engineers (ASCE)
· Coordinacion de Publicaciones de la Escuela Superior de Economia
M. Mosley, J. A. Kline · CLOCKSS Archive
· Universidad Nacional Autonoma de Mexico
· Universidad Nacional Autonoma de Mexico
Live discovery
Live results from PubMed, ClinicalTrials.gov and UniProt. These may not yet have been reviewed or stored in the Data Hub.
Fitzbio provides educational and research reference material. It does not diagnose, prescribe or replace advice from a qualified healthcare professional.
